Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients

General Physiology and Biophysics

Volumn 23, Issue 4, 2004, Pages 387-399

  Merzouk, S ^a   Hichami, A ^b   Sari, A ^c   Madani, S ^b   Merzouk, H ^a   Yahia Berrouiguet, A ^d   Lenoir Rousseaux, J J ^e   Chabane Sari, N ^a   Khan, Naim A ^b  

^a UNIVERSITY OF TLEMCEN   (Algeria)

^b UFR sciences de la vie   (France)

^c INSERM   (France)

^d Ctr Hosp Universitaire de Tlemcen   (Algeria)

^e UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Antioxidant status; Diabetes mellitus; Fatty acids; LDL

Indexed keywords

CALCIUM ANTAGONIST; COPPER SULFATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; HYDROPEROXIDE; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; ORAL ANTIDIABETIC AGENT; OXYGEN RADICAL; SULFONYLUREA;

ABSORPTION; ADULT; ANGINA PECTORIS; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; FEMALE; HEART INFARCTION; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS;

ADULT; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; FATTY ACIDS; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

ANGINA;

EID: 14844361737     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Balkan J., Kanbagli O., Mehmetcik G., Mutlu-Turkoglu U., Aykac-Toker G., Uysal M. (2002): Increased lipid peroxidation in serum and low density lipoproteins associated with aging in humans. Int. J. Vitam. Nutr. Res. 72, 315-320
2. Baynes J. W. (1991): Role of oxidative stress in development of complication in diabetes. Diabetes 40, 405-412
3. Beaudeux J. L., Guillausseau P. J., Peynet J., Flourie F., Assayag M., Tielmans D., Warnet A., Rousselet F. (1995): Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. Clin. Chim. Acta 239, 131-141
4. Berg T. J., Nourooz-Zadeh J., Wolff S. P., Tritschler H. J., Bangstad H. J., Hanssen K. F. (1998): Hydroperoxides in plasma are reduced by intensified insulin treatment. Diabetes Care 21, 1295-1300
5. Bonnefont-Rousselot D., Bastard J. P., Jaudon M. C., Delattre J. (2000): Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab. 26, 163-176
6. Brownlee M. (1994): Glycation and diabetic complication. Diabetes 43, 836-841
7. Cao G., Alessio H. M., Cutler R. G. (1993): Oxygen-radical absorbance capacity assay for antioxidants. Free Radic. Biol. Med. 14 303-311
8. Courderot-Masuyer C., Lahet J. J., Verges B., Brun J. M., Rochette L. (2000): Ascorbyl free radical release in diabetic patients. Cell. Mol. Biol. 46, 1397-1401
9. Dimitriadis E., Griffin M., Owens D., Johnson A., Collins P., Tomkin G. H. (1995): Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition. Diabetologia 38, 1300-1306
10. Dullaart R. P. F. (1995): Plasma lipoprotein abnormalities in type 1 diabetes mellitus. Neth. J. Med. 46, 44-54
11. Feillet C., Roche B., Tauveron I., Bayle D., Rock E., Borel P., Rayssiguier Y., Thieblot P., Mazur A. (1998): Susceptibility to oxidation and physicochemical properties of LDL in insulin-dependent diabetics. Atherosclerosis 136, 405-407
12. Folch J., Lees M., Sloane-Stanley G. H. (1957): A simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509
13. Ginsberg H. N. (1991): Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 14 839-855
14. Giugliano D., Ceriello A., Paolisso G. (1995): Diabetes mellitus, hypertension, and cardiovascular disease: which role of oxidative stress? Metabolism 44, 363-368
15. Gokkusu C., Palanduz S., Ademoglu E., Tamer S. (2001): Oxidant and antioxidant systems in NIDDM patients: influence of vitamine E supplementation. Endocr. Res. 27, 377-386
16. Havel R. J., Eder H. A., Bragdon J. H. (1955): The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353
17. Holvoet P., Collen D. (1998): Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 137, 33-38
18. Inouye M., Moi T., Sumino K. (1999): Link between glycation and lipoxidation in red blood cells in diabetes. Clin. Chim. Acta 285 35-44
19. Jenkins A. J., Klein R. L., Chassereau C. N., Hermayer K. L., Lopes-Virella M. F. (1996): LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. Diabetes 45, 762-767
20. Kaplan L. A., Cline D., Gartside P., Burnstein S., Sperling M., Stein E. A. (1982): Hemoglobin A1 in hemolysates from healthy and insulin-dependent diabetic children, as determined with a temperature-controlled mini column assay. Clin. Chem. 28, 13-18
21. Klimov A. N., Gurevich V. S., Nikiforova A. A., Shatilina L. V., Kuzmin A. A., Plavinsky S. L., Teryukova N. P. (1993): Antioxidative activity of high density lipoproteins in vivo. Atherosclerosis 100, 13-18
22. Kondo A., Murunaka Y., Ohta I., Notsu K., Manabe M., Kotani K., Saito K., Maekawa M. (2001): Relationships between TG concentrations and LDL size evaluated by malonadehyde-modified LDL. Clin. Chem. 47 893-900
23. Liguori A., Abete P., Hayden J. M., Cacciatore F., Rengo F., Ambrosio G., Bonaduce D., Condorelli M., Reaven P. D., Napoli C. (2001): Effect of glycaemic control and age on low density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. Eur. Heart J. 22, 2075-2084
24. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. I. (1951): Protein measurement with folin phenol reagent. J. Biol. Chem. 193, 265-275
25. Maxwell S. R., Thomason H., Sandler D., LeGuen C., Baxter M. A., Thorpe G. H., Jones A. F., Bartet A. H. (1997): Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 27, 484-490
26. Merzouk S., Hichami A., Madani S., Merzouk H., Berrouiguet A. Y., Prost J., Moutairou K., Chabane-Sari N., Khan N. A. (2003): Antioxidant status and levels of different vitamins determined by high perfomance liquid chromatography in diabetic subjects with multiple complications. Gen. Physiol. Biophys. 22, 15-27
27. Nourooz-Zadeh J., Rahimi A., Tajaddini-Sarmadi J., Tritschler H., Rosen P., Halliwell B., Betteridge D. J. (1997): Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40, 647-653
28. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Ling K. L. E., Wolff P. S. (1996): Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations. Biochem. J. 313, 781-786
29. Pelikanova T., Kohout M., Base J., Stefska Z., Kovar J., Kazdova L., Valek J. (1991a): Effect of acute hyperinsulinemia on fatty acid composition of serum lipids non-insulin-dependent diabetics and healthy men. Acta Clin. Chim. 203, 329-338
30. Pelikanova T., Kohout M., Valek J., Base J., Stefska Z. (1991b): Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (non insulin dependent) diabetic men. Metabolism 40, 175-180
31. Pelikanova T., Kazdova L., Chvojkova S., Base J. (2001): Serum fatty acid composition and insulin action in type 2 diabetic patients. Metabolism 50, 1472-1478
32. Pieri C., Testa R., Marra M., Bonfigli A. R., Manfrini S., Testa I. (2001): Age dependent changes of serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-dependent diabetic patients. Gerontology 47, 88-92
33. Prescott J., Owens D., Collins P., Johson A., Tomkin G. H. (1999): The fatty acid distribution in low density lipoproteins in diabetes. Biochim. Biophys. Acta 1439, 110-116
34. Rabini R. A., Tesei M., Galeazzi T., Dousset N., Ferretti G., Mazzanti L. (1999): Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: a possible correlation with fatty acid composition. Mol. Cell. Biochem. 199, 63-67
35. Salomaa V., Ahota I., Tuomilehto J., Aro A., Pietinen P., Korhonen H. J., Penttila I. (1990): Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism 39, 1285-1291
36. Sangvanich P., Mackness B., Gaskell S. J., Durrington P., Mackness M. (2003): The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein. Biochem. Biophys. Res. Com. 300, 501-506
37. Semenkovich C. F., Heinecke J. W. (1997): The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes 46, 327-334
38. Sinclair A. J. (1993): Free radical mechanisms and vascular complications of diabetes mellitus. Diabetes Rev. 2, 7-10
39. Therond P., Bonnefont-Rousselot D., Davit-Spraul A., Conti M., Legrand A. (2000): Biomarkers of oxidative stress: an analytical approach. Curr. Opin. Clin. Nutr. Metab. Care 3, 373-384
40. Thomas M. J. (2000): Physiological aspects of low density lipoprotein oxidation. Curr. Opin. Lipidol. 11, 297-301
41. Tsai E. C., Hirsch I. B., Brunzell J. D., Chait A. (1994): Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43, 1010-1014
42. Vanderjagt D. J., Harrison J. M., Ratliff D. M., Hunsaker L. A., Vanderjagt D. L. (2001): Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin. Biochem. 34 265-270
43. Vessby J., Basu S., Mohsen R., Berne C., Vessby B. (2002): Oxidative stress and antioxidant status in type 1 diabetes mellitus. J. Intern. Med. 251, 69-76
44. Witztum J. L. (1994): The oxidation hypothesis of atherosclerosis. Lancet 344, 793-795
45. Wolff S. P., Dean R. T. (1987): Glucose autoxidation and protein modification: the potential role of autoxidative glycosylation in diabetes. Biochem. J. 245, 243-250